mRNA Services Platform
Design and production of mRNA
- Design and optimization of mRNA sequences
- Utilizing the design and optimization techniques for mRNA sequences, UTR screening, and codon optimization
- Plasmid and DNA template productions for in vitro transcription
- Employment of a classical three-step purification method
- Implementation of mono-enzyme digestion and purification through chromatography
- Research scale mRNA production and characterization
- Generation of conventional 5’ capped mRNA with chemically modified nucleosides (optional: a two-step method)
- Analysis of purity, integrity, capping efficiency, poly A length and dsRNA residue, and endotoxins residue
mRNA delivery system
- mRNA delivery
- LNP (microfluidic system) and others
✓ Tissue targeted LNP
✓ SORT strategy - Lipoplexes (LPX)
- LNP (microfluidic system) and others
- Characterizations
- Particle size distribution
- Polydispersity index (PDI)
- Zeta potential
- pKa
- Encapsulation efficiency
- Particle morphology
- Endotoxin residue
In vitro and in vivo evaluations
In vitro and in vivo delivery and biodistribution
- Cell lines: over 1500 cell lines and patient-derived fibroblasts, establishment of
customized stable cell lines - Primary cells: primary hepatocytes of human, mouse, rat, dog and monkey;
availability of other customized primary cells - Animal models: various species of rodents and NHP
- Methods for evaluations of mRNA uptake and protein expression: bDNA,
LC/MS, HCS, ELISA , Western blot, flow cytometry, IF and more - In vivo delivery and biodistribution: live image system.

Flyer_Supporting Discovery of mRNA Drugs
Related Content
RNA therapeutics can target specific mRNAs with high specificity, making them advantageous for treating genetic diseases caused by known mutations....
VIEW RESOURCESince the approval of the first siRNA drug in 2018, oligonucleotide therapeutics have rapidly emerged as a promising drug modality. ...
VIEW RESOURCE
